Small observational studies and case reports have examined outcomes in patients with type 2 diabetes and concurrent IBD who were prescribed GLP-1 agonists for glycemic control
The medication's impact on digestion can cause various symptoms, including cramping, bloating, and general discomfort
At the same time, the incidence of diabetic nephropathy, although reduced compared to 20 years ago, is stabilized in recent years, and the incidence of end-stage renal disease (due to reduced cardiovascular mortality and increased life expectancy) is increasing [64]
Yazdani, I., Majdani, R., Ghasemnejad-berenji, M
Marketing unapproved drugs: The FDA issued warning letters to companies that marketed compounded GLP-1 medications with claims that went beyond what is permissible for compounded products
Is nasal spray as strong as injections